Ads
related to: multiple sclerosis treatment- MS Symptoms
Learn More About Multiple
Sclerosis Signs And Symptoms.
- Stay Informed
Sign Up To Get The Latest
Updates And More Info.
- Patient Ambassador
Learn About MS Patient
Ambassador Program.
- For Care Partners
Resources For Those Who Support
A Friend Or A Loved One With MS
- MS Symptoms
Search results
Drug resistant infections reported after stem cell treatments in Mexico
Becker’s Hospital Review· 5 days agoThe report describes three patients who acquired the infections during stem cell injections at two clinics in the Mexican border state of Baja California. It is not clear what caused the outbreak ...
Colorado hospitals detect 3 cases of infections linked to stem-cell treatments received in Mexico
Denver Post· 4 days agoThe first case was reported in late 2022, in a woman who had embryonic stem-cell treatment in...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript May 8, 2024 Vanda...
Vanda Pharmaceuticals Inc (VNDA) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 6 days agoVanda Pharmaceuticals Inc (NASDAQ:VNDA) acquired PONVORY, enhancing its product portfolio with a treatment approved for multiple sclerosis</ ...
Clene (NASDAQ: CLNN) Releases Q1 2024 Financial Numbers, Operation Highlights
Digital Journal· 5 days agoClene Nanomedicine is a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases. Highlights of the report include ...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
WPRI Providence· 5 days agoCelltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale ...
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
Digital Journal· 5 hours agoTop-line data from first-in-human Phase 1a clinical trial of PMN310 as a treatment for Alzheimer’s disease on track for mid-2024CAMBRIDGE, Massachusetts and TORONTO, Ontario ...
Q1 2024 Vanda Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoTurning now to PONVORY. With the December 2023 acquisition of PONVORY, this makes the third commercial stage product for Vanda. Currently approved as a once-a-day oral treatment< ...
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoRoyalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript May 9, 2024 Royalty Pharma plc...
Exploring Three Dividend Stocks On Euronext Paris
Simply Wall St. via Yahoo Finance· 19 hours agoAmidst a backdrop of rising optimism in European markets, where indices like France's CAC 40 have recently seen significant gains, investors are...